High mid-treatment RNA disruption in patients with HER2-negative breast cancer predicts survival benefit after neoadjuvant chemotherapyLaura B. Pritzker,Mads Haugland Haugen,Hedda von der Lippe Gythfeldt, Twinkle Masilamani, Gabriel Theriault, Renee St-Onge,Lavina D'costa,Ole Christian Lingjaerde,Amadeo Parissenti,Olav EngebraatenCANCER RESEARCH(2022)引用 1|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要